Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Lindenmann, J; Fediuk, M; Fink-Neuboeck, N; Porubsky, C; Pichler, M; Brcic, L; Anegg, U; Balic, M; Dandachi, N; Maier, A; Smolle, M; Smolle, J; Smolle-Juettner, FM.
Hazard Curves for Tumor Recurrence and Tumor-Related Death Following Esophagectomy for Esophageal Cancer.
Cancers (Basel). 2020; 12(8):
PubMed FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Anegg Udo
Balic Marija
Brcic Luka
Dandachi Nadia
Fediuk Melanie
Fink-Neuböck Nicole
Lindenmann Jörg
Maier Alfred
Pichler Martin
Porubsky Christian
Smolle Josef
Smolle Maria
Smolle-Juettner Freyja-Maria
Altmetrics:

Dimensions Citations:

Plum Analytics:
Abstract:
The knowledge of both patterns and risk of relapse following resection for esophageal cancer is crucial for establishing appropriate surveillance schedules. The aim of this study was to evaluate the pattern of hazards for tumor recurrence and tumor-related death in the postoperative long-term follow-up after esophagectomy. Retrospective single-center analysis of 362 patients, with resected esophageal cancer. Multivariate Cox proportional hazard model was used. A total of 192 (53%) had postoperative tumor recurrence. The relapse patterns of adenocarcinoma and squamous-cell carcinoma showed that each had a single peak, 12 months after surgery. After induction there was one peak at 5 months, the non-induced patients peaked 11 months, postoperatively. At 18 months, the recurrence hazard declined sharply in all cases. The hazard curves for tumor-related death were bimodal for adenocarcinoma, with two peaks at 6 and 22 months and one single peak for squamous-cell carcinoma at 18 months after surgery, showing pronounced decline later on. In curatively resected esophageal cancer, both tumor recurrence hazard and hazard for tumor-related death showed distinct, partly bimodal patterns. It could be justified to intensify the surveillance during the first two postoperative years by initiating a close-meshed follow-up to detect and treat tumor recurrence, as early as possible.

© Med Uni Graz Impressum